European Review for Medical and Pharmacological Sciences
European Review for Medical and Pharmacological Sciences is a peer-reviewed medical journal that publishes comprehensive research articles in the field of medicine and pharmacology. Established with the aim of disseminating significant and up-to-date scientific information, the journal has become a pivotal platform for researchers, clinicians, and pharmacologists worldwide. It covers a broad spectrum of topics, including but not limited to, clinical medicine, pharmacotherapy, drug efficacy, pharmacodynamics, pharmacokinetics, and biomedical research.
Overview[edit | edit source]
The European Review for Medical and Pharmacological Sciences focuses on the publication of original research articles, review articles, case reports, and short communications that contribute significantly to the medical and pharmacological sciences. The journal is committed to enhancing the understanding of disease processes and improving the management and treatment of diseases. It encourages submissions that explore innovative pharmacological treatments, novel diagnostic procedures, and cutting-edge research in genetics, molecular biology, and biochemistry.
Publication Frequency[edit | edit source]
The journal is published on a monthly basis, ensuring that the medical and scientific community has regular access to the latest research findings. Each issue is carefully curated to include articles that have undergone rigorous peer review, ensuring the accuracy, relevance, and scientific merit of the published work.
Editorial Board[edit | edit source]
The editorial board of the European Review for Medical and Pharmacological Sciences comprises distinguished scientists and researchers from across the globe. These experts bring a wealth of knowledge and experience to the journal, overseeing the peer review process and guiding the journal's editorial policies. Their expertise ensures that the journal maintains high standards of scientific integrity and excellence.
Indexing and Abstracting[edit | edit source]
The journal is indexed and abstracted in several prestigious databases, including PubMed, Scopus, and the Science Citation Index Expanded. This wide indexing helps in enhancing the visibility and accessibility of the articles published in the journal, allowing researchers and practitioners easy access to the latest research findings.
Open Access[edit | edit source]
European Review for Medical and Pharmacological Sciences operates on an open access model, providing unrestricted online access to its articles. This approach facilitates the dissemination of research findings to a broader audience, including scientists, clinicians, and the general public, thereby promoting the advancement of medical and pharmacological knowledge.
Submission Guidelines[edit | edit source]
Authors wishing to submit their work to the European Review for Medical and Pharmacological Sciences must adhere to the journal's submission guidelines. These guidelines detail the manuscript preparation, submission process, and ethical considerations. The journal emphasizes the importance of ethical research practices and requires all submissions to comply with international ethical standards.
Impact Factor[edit | edit source]
The impact factor of a journal is a measure of the frequency with which the average article in a journal has been cited in a particular year. The European Review for Medical and Pharmacological Sciences consistently strives to publish high-quality research that has the potential to make a significant impact in the field of medical and pharmacological sciences.
Conclusion[edit | edit source]
The European Review for Medical and Pharmacological Sciences plays a crucial role in the dissemination of medical and pharmacological research. Its commitment to publishing high-quality, peer-reviewed articles makes it an essential resource for researchers, clinicians, and pharmacologists seeking to expand their knowledge and contribute to the advancement of medical science.
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD